Belumosudil (Rezurock)

Status:
Do Not Prescribe (DNP)
Decision Date:
September 2022
 

Comments

DO NOT PRESCRIBE (DNP)

  • Treatment of patients aged ≥12 years with chronic graft-versus-host disease who have received ≥2 prior lines of systemic therapy.

Awaiting clinician request. 

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app